Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-01

Clinical Trial Update: PRET: Patients Prone to Recurrence After Endovascular Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on patients prone to recurrence after endovascular treatment for intracranial aneurysm and subarachnoid hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Intracranial Aneurysm, Subarachnoid Hemorrhage | Phase 4 | Status: COMPLETED | Results posted: 2019-03-01